SCHEMBL3891455

SCHEMBL3891455

CC(C)Oc1c[c]ccc1N1CCN(C)CC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 1/20 0.44
▸ DRD3 P35462 1/20 0.44
▸ ADRA1A P35348 6/20 0.43
▸ ADRA1B P35368 6/20 0.43
▸ ADRA1D P25100 5/20 0.43
▸ ADRA2C P18825 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ ALK Q9UM73 1/20 0.35
▸ DRD4 P21917 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ GFER P55789 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PTK2B Q14289 1/20 0.34
▸ ESR2 Q92731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL188354 0.83 DRD2 (0.60) DRD2DRD3ADRA1AADRA1BADRA1D
SCHEMBL27651774 0.78 DRD2 (0.43) DRD2DRD3ADRA2CALDH1A1L3MBTL1
SCHEMBL14621895 0.78 DRD2 (0.67) DRD2DRD3ADRA1AADRA1BADRA1D
SCHEMBL4117842 0.76 ADRA2C (0.39) DRD2DRD3ADRA2CALDH1A1HTR1A
SCHEMBL8513730 0.74 ADRA2C (0.37) DRD2DRD3ADRA2CALDH1A1HTR1A
SCHEMBL188362 0.74 ADRA2C (0.42) DRD2DRD3ADRA2CALDH1A1HTR1A
SCHEMBL4113163 0.74 DRD2 (0.51) DRD2DRD3ADRA2CALDH1A1HTR1A
SCHEMBL285241 0.73 DRD2 (0.60) DRD2DRD3ADRA1AADRA1BADRA1D
SCHEMBL3582056 0.73 ADRA2C (0.39) DRD2DRD3ADRA2CALDH1A1HTR1A
SCHEMBL3400411 0.73 DRD2 (0.59) DRD2DRD3ADRA1AADRA1BADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2010496-A1 4-ANILINOQUINOLINE-3-CARBOXAMIDES AS CSF-1R KINASE INHIBITORS AstraZeneca AB (SE) 2009-01-07 — — EP disclosed
WO-2007119046-A1 4-ANILINOQUINOLINE-3-CARBOXAMIDES AS CSF-1R KINASE INHIBITORS ASTRAZENECA AB (SE) 2007-10-25 — — WO disclosed
Send feedback